Cutting edge: Dendritic cells require maturation via CD40 to generate protective antitumor immunity

Journal of Immunology

Volumn 161, Issue 5, 1998, Pages 2094-2098

  Mackey, Matthew F ^a   Gunn, Jason R ^a   Maliszewski, Charles ^b   Kikutani, Hitoshi ^c   Noelle, Randolph J ^a   Barth Jr , Richard J ^a,d  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b AMGEN INC   (United States)

^c OSAKA UNIVERSITY   (Japan)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GLYCOPROTEIN GP 39; INTERLEUKIN 12; TUMOR ANTIGEN; TUMOR VACCINE; CD40 LIGAND; CYTOKINE; LIGAND; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENETIC TRANSDUCTION; HELPER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR IMMUNITY; VACCINATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOUSE MUTANT; PASSIVE IMMUNIZATION; PHYSIOLOGY; SARCOMA; TH1 CELL; TRANSPLANTATION;

ANIMALS; ANTIGENS, CD40; CD40 LIGAND; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; FEMALE; IMMUNIZATION, PASSIVE; INTERLEUKIN-12; LIGANDS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; SARCOMA, EXPERIMENTAL; TH1 CELLS; TUMOR CELLS, CULTURED;

EID: 0032160577     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Durie, F. H., T. M. Foy, S. R. Masters, J. D. Laman, and R. J. Noelle. 1994. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today 15:406.
2. Mackey, M., R. J. Barth, Jr., and R. J. Noelle. 1998. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J. Leukocyte Biol. 63:418.
3. Roy, M., A. Aruffo, J. A. Ledbetter, P. Linsley, M. Kehry, and R. J. Noelle. 1995. Studies on the independence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25:596.
4. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, K. C. Van, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263.
5. Kiener, P. A., D. P. Moran, B. M. Rankin, A. F. Wahl, A. Aruffo, and D. Hollenbaugh. 1995. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol. 155:4917.
6. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med 184:747.
7. Koch, F., U. Stanzyl, P. Jennewein, K. Janke, C. Heufler, E. Kampgen, N. Romani, and G. Schuler. 1996. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184:741.
8. Campbell, K. A., P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed, and C. R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283.
9. + T cells. J. Immunol. 154:5071.
10. Buhlmann, J. E., T. M. Foy, A. Aruffo, K. M. Crassi, J. A. Ledbetter, W. R. Green, J. C. Xu, L. D. Shultz, D. Roopesian, R. A. Flavell, L. Fast, R. J. Noelle, and F. H. Durie. 1995. In the absence of a CD40 signal, B cells are tolerogenic. Immunity 2:645.20.
11. Mackey, M. F., J. R. Gunn, P. P. Ting, H. Kikutani, G. Dranoff, R. J. Noelle, and R. J. Barth. 1997. Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154. Cancer Res. 57:2569.
12. Kamanaka, M., P. Yu, T. Yasui, K. Yoshida, T. Kawabe, T. Horii, T. Kishimoto, and H. Kikutani. 1996. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4:275.
13. Summerhayes, I. C., and L. M. Franks. 1979. Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro. J. Natl. Cancer Inst. 62:1017.
14. Hawley, R. G., T. S. Hawley, A. Z. Fong, C. Quinto, M. Collins, J. P. Leonard, and S. J. Goldman. 1996. Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11. Proc. Natl. Acad. Sci. USA 93:10297.
15. Steinman, R. M., G. Kaplan, M. D. Witmer, and Z. A. Cohn. 1979. Identification of a novel cell type in peripheral lymphoid organs of mice: functional properties in vitro. J. Exp. Med. 149:1.
16. Maraskovsky, E., K. Brasel, M. Teepe, E. R. Roux, S. D. Lyman, K. Shortman, and H. J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953.
17. Chou, T., and S. Shu. 1987. Cellular interactions and the role of IL-2 in the expression and induction of immunity against a syngeneic murine sarcoma. J. Immunol. 139:2103.
18. Barth, R. J., and J. J. Mule. 1996. Cytokine gene transfer into tumor cells: animal models. In Gene Therapy in Cancer. R. Moen and M. Brenner, eds. Marcel Dekker, Inc., New York, p. 73.
19. + tumor-infiltrating lymphocytes. J. Exp. Med. 173:647.
20. Stuber, E., W. Strober, and M. Neurath. 1996. Blocking of CD40-CD40L interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 183:693.
21. Cella, M., A. Engering, V. Pinet, J. Pieters, and A. Lanzavecchia. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388:782.
22. Iezzi, G., K. Karjalainen, and A. Lanzavecchia. 1998. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8:89.
23. Porgador, A., and E. Gilboa. 1995. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 182:255.
24. Zitvogel, L., J. I. Mayordomo, T. Tjandrawan, A. B. DeLeo, M. R. Clarke, M. T. Lotze, and W. J. Storkus. 1996. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183:87.
25. Porgador, A., D. Snyder, and E. Gilboa. 1996. Induction of antitumor immunity using bone marrow-generated dendritic cells. J. Immunol. 156:2918.
26. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.